| Sarah M Nagle-yang, MD | |
|
13001 E 17th Pl Fl 2, Aurora, CO 80045-2570 | |
| (303) 724-1000 | |
| (303) 724-9472 |
| Full Name | Sarah M Nagle-yang |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 19 Years |
| Location | 13001 E 17th Pl Fl 2, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437388121 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
So far this year, numbers of measles cases are still at relatively low levels; there were 150 confirmed cases in the first half of 2004 compared with 296 cases in the same period in 2003.
Proteins are the main actors in our body: They transport substances, convey messages or carry out vital processes in their role as molecular machines. The "helmsmen of the cell" are composed of amino acids, whose sequence is already defined by the heritable information in every living being. The translation of this information during the production of proteins (protein synthesis) is determined by the genetic code.
"The efforts of public agencies, non-governmental organisations, private entities and international agencies have become indispensable in addressing the food crisis" in Guatemala, however "activists believe a greater public effort is necessary," Inter Press Service reports. The article examines efforts by various agencies working in Guatemala including the Rural Development Programme for Las Verapaces (PRODEVER), and Accion Contra el Hambre, a local anti-hunger organization.
A group of researchers led by scientists from the Virginia Bioinformatics Institute at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test.
Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in on this new target are underway.
› Verified 5 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
So far this year, numbers of measles cases are still at relatively low levels; there were 150 confirmed cases in the first half of 2004 compared with 296 cases in the same period in 2003.
Proteins are the main actors in our body: They transport substances, convey messages or carry out vital processes in their role as molecular machines. The "helmsmen of the cell" are composed of amino acids, whose sequence is already defined by the heritable information in every living being. The translation of this information during the production of proteins (protein synthesis) is determined by the genetic code.
"The efforts of public agencies, non-governmental organisations, private entities and international agencies have become indispensable in addressing the food crisis" in Guatemala, however "activists believe a greater public effort is necessary," Inter Press Service reports. The article examines efforts by various agencies working in Guatemala including the Rural Development Programme for Las Verapaces (PRODEVER), and Accion Contra el Hambre, a local anti-hunger organization.
A group of researchers led by scientists from the Virginia Bioinformatics Institute at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test.
Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in on this new target are underway.
› Verified 5 days ago
| Entity Name | University Of Colorado Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1982944054 PECOS PAC ID: 1052223724 Enrollment ID: O20131014000076 |
News Archive
So far this year, numbers of measles cases are still at relatively low levels; there were 150 confirmed cases in the first half of 2004 compared with 296 cases in the same period in 2003.
Proteins are the main actors in our body: They transport substances, convey messages or carry out vital processes in their role as molecular machines. The "helmsmen of the cell" are composed of amino acids, whose sequence is already defined by the heritable information in every living being. The translation of this information during the production of proteins (protein synthesis) is determined by the genetic code.
"The efforts of public agencies, non-governmental organisations, private entities and international agencies have become indispensable in addressing the food crisis" in Guatemala, however "activists believe a greater public effort is necessary," Inter Press Service reports. The article examines efforts by various agencies working in Guatemala including the Rural Development Programme for Las Verapaces (PRODEVER), and Accion Contra el Hambre, a local anti-hunger organization.
A group of researchers led by scientists from the Virginia Bioinformatics Institute at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test.
Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in on this new target are underway.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah M Nagle-yang, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Sarah M Nagle-yang, MD 13001 E 17th Pl Fl 2, Aurora, CO 80045-2570 Ph: (303) 724-1000 |
News Archive
So far this year, numbers of measles cases are still at relatively low levels; there were 150 confirmed cases in the first half of 2004 compared with 296 cases in the same period in 2003.
Proteins are the main actors in our body: They transport substances, convey messages or carry out vital processes in their role as molecular machines. The "helmsmen of the cell" are composed of amino acids, whose sequence is already defined by the heritable information in every living being. The translation of this information during the production of proteins (protein synthesis) is determined by the genetic code.
"The efforts of public agencies, non-governmental organisations, private entities and international agencies have become indispensable in addressing the food crisis" in Guatemala, however "activists believe a greater public effort is necessary," Inter Press Service reports. The article examines efforts by various agencies working in Guatemala including the Rural Development Programme for Las Verapaces (PRODEVER), and Accion Contra el Hambre, a local anti-hunger organization.
A group of researchers led by scientists from the Virginia Bioinformatics Institute at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test.
Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in on this new target are underway.
› Verified 5 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |